On-Demand Webinars

1. Innovating Upstream Manufacturing For The Next Wave Of Gene Therapies 3/4/2026

   Explore a streamlined approach to transient AAV production, including yield improvements across serotypes, key transfection parameters, and practical guidance for scaling processes.

2. USP <665> Compliance Guidance 2/26/2026

   Experts address key USP <665> questions, including risk assessment, testing approaches, extractables and leachables, and practical challenges in implementing single‑use systems in manufacturing.

3. Practical Considerations For Aseptic Gowning In Contamination Control Strategies 2/26/2026

   Master the complexities of aseptic gowning and Annex 1 compliance. Explore risk-based strategies to mitigate human-source contamination and strengthen your facility's sterility assurance.

4. Optimizing Antibody Variant Capture: Strategies To Combat Aggregation, Impurities, And Low Yields 2/26/2026

   Explore how process conditions affect bispecific antibody stability and impurity formation, as well as practical strategies to minimize aggregation and remove product‑related variants.

5. Integrated Thinking for Complex FIH Programs 2/25/2026

   See how deep expertise, integrated thinking, and cross-functional collaboration turn complex molecule challenges into opportunities, strengthening early decisions and improving First‑in‑Human outcomes.

6. Four Common Pitfalls To Avoid In UF/DF Setup And Scale-Up 2/18/2026

   Learn how small UF/DF decisions can create major scale-up challenges, as well as practical ways to improve membrane selection, reduce manual operations, and boost PD–MSAT alignment.

7. Flexibility Or Scale? Navigating The Single Use Vs. Stainless Steel Debate 2/12/2026

   Explore how to choose between single‑use and stainless‑steel bioreactors, outlining key advantages, limitations, and long‑term considerations essential for successful biologics scale‑up.

8. Bridging Discovery And CMC With Rapid Pools 2/10/2026

   Learn how early stable CHO expression data reveals manufacturability issues in complex antibodies that transient screening misses, with case studies showing how this changes lead selection.

9. Imagine The Future: An Enhanced Oligonucleotide Synthesis Process 2/9/2026

   Gain practical guidance for improving oligo quality, see how an advanced synthesis platform supports production, and explore a software interface designed to make daily operations more intuitive.

10. Your AKTA Oligosynt™ System : It's More Than A Machine 2/9/2026

    Discover how early choices in oligo synthesis workflows shape performance. Learn what to consider across design, reagents, and system optimization to build a process ready for smooth scale‑up.